Francesco Draetta

Francesco Draetta

Director/Board Member en Beta Bionics, Inc. .

39 años
Finance
Consumer Services
Health Technology

Perfil

Francesco is a Partner at Omega Funds, where he focuses on early-stage investments and fundraising for the firm.
Francesco currently serves on the Board of Directors of NRG Therapeutics and as a board observer for ARTBIO and LEXEO Therapeutics.
He previously served as a Board Director for Chord Therapeutics (acquired by Merck KGaA) and as a Board Observer for Amunix Pharmaceuticals (acquired by Sanofi).
Prior to rejoining Omega in 2016, Francesco was part of the investment team at Brookside Mezzanine Partners and at Commonfund Capital.
He began his career at Omega Funds as an Analyst.
Francesco is a CFA charterholder, a CAIA charterholder, and a Certified FRM.
He graduated cum laude from the Isenberg School of Management at the University of Massachusetts Amherst with a BBA in Finance and Operations Management.

Cargos activos de Francesco Draetta

EmpresasCargoInicio
Private Equity Investor 01/01/2018
Director/Board Member 01/06/2022
Director/Board Member -
Todos los cargos activos de Francesco Draetta

Antiguos cargos conocidos de Francesco Draetta.

EmpresasCargoFin
OMEGA ALPHA SPAC Founder 01/01/2023
Director/Board Member 31/01/2022
Corporate Officer/Principal -
Ver el detalle de la experiencia de Francesco Draetta.

Formación de Francesco Draetta.

The Isenberg School of Management Graduate Degree
American School of Milan Graduate Degree
University of Massachusetts Amherst College of Natural Science Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Francesco Draetta.

Relaciones

48

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas6

Finance

Finance

Health Technology

Health Technology

Finance

Commercial Services

Ver las conexiones de la empresa
  1. Bolsa
  2. Insiders
  3. Francesco Draetta